gimli
ASTRAZEN stock analysis context
ASTRAZENECA PHARMA IND LT Stock Context for AI Screening
ASTRAZENECA PHARMA IND LT is a mid-cap stock in Healthcare. This page summarizes key screening signals for ASTRAZENECA PHARMA IND LT, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about ASTRAZENPrice
₹8,587.50
1M return
+1.75%
3M return
-3.40%
Market cap
₹21,468.75 cr
PE
106.87
ROE
+27.11%
RSI
55.39
Turnover
₹1.46 cr
Why it can matter in screens
- Momentum: ASTRAZEN is above 50DMA; RSI is 55.39.
- Returns: 1M +1.75%, 3M -3.40%, 6M -4.46%.
- Liquidity: latest turnover is ₹1.46 cr.
- Valuation: PE 106.87, PB n/a, ROE +27.11%, ROCE +36.21%.
- Growth: 3Y sales CAGR +28.59%, 3Y profit CAGR +23.39%.
Try these prompts
- Analyze ASTRAZENECA PHARMA IND LT with valuation, momentum and industry peers
- Compare ASTRAZEN with other Healthcare stocks
- Show mid-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View mid-cap stocks
- Find stocks above 50DMA
- Compare ASTRAZEN with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.